Stay updated on Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial
Sign up to get notified when there's something new on the Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial page.

Latest updates to the Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial page
- Check4 days agoChange DetectedThe page’s release/version text has been updated to a newer site revision (v3.5.3). It also removes a general “Prostate cancer” related topics section that appeared in the previous version (including MedlinePlus Genetics), reflecting a non-clinical content/nav update.SummaryDifference0.2%

- Check11 days agoChange DetectedRevision: v3.5.2 replaces the previous v3.5.0.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRemoved 'Prostate cancer' and 'MedlinePlus Genetics' from the related topics section.SummaryDifference0.2%

- Check32 days agoChange DetectedAdded Prostate cancer to related topics and included MedlinePlus Genetics as a related topic.SummaryDifference0.2%

- Check39 days agoChange DetectedThe revision indicator on the page was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision: v3.4.3; the investigator name and site (Mark Garzotto, MD, Portland VA Medical Center) and the prior revision reference (v3.4.2) were removed.SummaryDifference0.6%

Stay in the know with updates to Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial page.